DJT heads into mid-June with its executive team selling shares at a steady clip — even as the stock has dropped nearly 10% on the week and sits at $8.16, close to its recent lows.
The insider story is the clearest signal this week. Every significant trade logged over the past 90 days has been a sale. The CFO, CTO, and General Counsel all sold in two separate rounds — once in mid-May and again on May 27 — with the unnamed CEO adding a further disposal on May 21. Net insider activity across the 90-day window amounts to just under $1.7 million in net sales. None of these are large transactions in dollar terms, but the pattern is uniform: no buyer among any disclosed executive or officer. Against a backdrop of a stock that has fallen over 8% in the past month, the directional message from insiders is unambiguous.
The positioning picture is less extreme than the insider flow might suggest, but not without tension. Short interest has actually been unwinding — down 26% over the past month to roughly 3.8% of the free float, a level that, while elevated, is meaningfully lower than the 5%-plus readings from early May. That de-risking by shorts coincides with the stock's slide, suggesting bears have been covering into weakness rather than pressing new positions. Borrow availability has loosened to around 57%, up sharply from the tightest point in the past year (10.7%), though the cost to borrow has ticked up 39% on the week to 0.86% — still low in absolute terms but worth watching if it continues rising. The ORTEX short score sits near 60, having pulled back from the low-60s earlier in the month, consistent with the gradual short-covering trend.
Options traders are leaning slightly bullish relative to recent norms, which cuts against the bearish insider and price signals. The put/call ratio is running at 0.72, a hair below its 20-day average of 0.74 — not a strong directional read, but marginally call-skewed. The 52-week range on the PCR tells the real story: this stock has seen readings as high as 1.43 and as low as 0.61, meaning current positioning is close to the middle of its historical band. There is no clear options-driven conviction in either direction.
The Street angle on DJT is thin. There is no recent analyst activity of note, and the valuation framework is difficult to apply in any traditional sense — the company's enterprise value is flagged at roughly $2.7 billion against a business with deeply negative return metrics, a Piotroski F-score of just 4, and a stock momentum rank near the bottom of the universe. Among the closest correlated peers, RDDT gained 5.3% on the week while RUM fell 16.5%, suggesting no consistent sector-wide read — DJT's price action, as it has been throughout its listed life, is driven by sentiment rather than fundamentals.
The next scheduled earnings date is July 31. Given that the last three prints produced negative one-day and five-day reactions — the most recent Q1 result on May 8 saw the stock fall 2.1% the day after and 3.9% over the following week — the question heading into summer is whether the steady drip of insider sales and the stock's continued drift lower changes the composition of the shareholder base before that next catalyst arrives.
See the live data behind this article on ORTEX.
Open DJT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
